Amvuttra

  • Brand name/Generic name: Amvuttra/vutrisiran
  • How Administered: subcutaneous injection
  • Duration of Treatment: two minutes
  • Frequency of Treatment: every 3 months
  • Conditions this Medication Treats: cardiomyopathy, polyneuropathy
  • Link for more Information: https://www.amvuttra.com/

Yin & Sound

This class from MoKa Yoga focuses on long, juicy stretches supported by props to help you gently release tension and stiffness. We’ll target areas that are often contracted, like those tight spots from sitting all day, and explore how to meet the unique needs of your body. To deepen your relaxation, the class also includes the soothing vibrations of singing bowls, which help quiet the mind and support the body’s natural healing response. Each yin pose is not only accessible during class but also something you can easily incorporate into your routine at home.

December 2025

Sun Mon Tue Wed Thu Fri Sat
30
1
2
3
4
5
6
 
 
 
 
 
 
 
7
8
9
10
11
12
13
 
 
 
 
 
 
 
14
15
16
17
18
19
20
 
 
 
 
 
 
 
21
22
23
24
25
26
27
 
 
 
 
 
 
 
28
29
30
31
1
2
3
 
 
 
 
 
 
 

Sound Bath

In the roots of yoga, rest is not aboidance, it's presence. It's a return to awareness. Under the full moon, we take time to be, not just do.  This sound bath invites you to reconnect with that intention. Come lie down, breath deeply, and be held in a space of stillness as sound carries you inward.

December 2025

Sun Mon Tue Wed Thu Fri Sat
30
1
2
3
4
5
6
 
 
 
 
 
 
 
7
8
9
10
11
12
13
 
 
 
 
 
 
 
14
15
16
17
18
19
20
 
 
 
 
 
Sound Bath 5:30 - 6:30 PM
 
 
 
21
22
23
24
25
26
27
 
 
 
 
 
 
 
28
29
30
31
1
2
3
 
 
 
 
 
 
 

Patient Newsletter 2025 April

Solid Tumor, TP-CA-007 “ARIES 006”

A Biobank Registry Platform Study in Oncology Patients with any solid tumor prior to starting treatment with any ADC

Lymphoma, GOLSEEK-1 CA073-1020

A Study to Compare the Efficacy and Safety of Golcadomide Plus R-CHOP vs Placebo Plus RCHOP in Participants with Previously Untreated High-risk Large B-cell Lymphoma

Prostate, TP-CA-007 “ARIES 005”

A Biobank Registry Platform Study in Oncology Patients with advanced or metastatic disease (Stage 3B, 3C, 4) castration resistant prostate cancer

Pages